Loading…
← Back to schedule
#615: Navigating the FDA Commissioner's National Priority Voucher Program: Implementation Insights and Strategic Impact
Wednesday June 17, 2026 10:15am - 11:30am EDT
204AB
Component Type: Forum
Level: Basic
CE: ACPE 1.25 Application UAN: 0286-0000-26-607-L04-P; CME 1.25; RN 1.25

The FDA Commissioner's National Priority Voucher (CNPV) program represents a novel regulatory mechanism designed to accelerate the development and review of drugs addressing critical public health priorities. This session provides a comprehensive analysis

Learning Objectives

Discuss the fundamental framework and eligibility criteria of the CNPV program; Analyze real implementation challenges and successful strategies; Evaluate the program's impact on expediting critical drug development and public health priorities.

Chair

Lina AlJuburi, PHARMD, MSC

Speaker

Panelist
Emel Mashaki Ceyhan

Panelist
Lawrence Eugene Liberti, RAC

Panelist
Kellie Taylor


Speakers
avatar for Lina AlJuburi

Lina AlJuburi

Head, Regulatory Science and Policy, North America, Sanofi, United States
A background in pharmacy and an interest in drug development and regulation led me to the US FDA where I spent several years within CDER, Office of New Drugs. By far the hardest decision, in 2012, I transitioned to the private sector in the field of Regulatory Science and Policy... Read More →
EM

Emel Mashaki Ceyhan

SVP & Head, Regulatory, Quality & Clinical Reporting (RQC), R&D, Novo Nordisk, Turkey
avatar for Elizabeth Lange

Elizabeth Lange

Executive Director/ Head of Regulatory Scientific Policy, EMD Serono, United States
Elizabeth Rosenkrands Lange is an experienced regulatory policy leader located in Washington DC. She is an Epidemiologist with a MPH. She has 18+ years of experience working in drug development, regulatory policy and patient advocacy. She began her career at the Danish Medicine Agency... Read More →
avatar for Lawrence Liberti

Lawrence Liberti

Director, D.K. Kim International Center for Regulatory Science, The Kim Center/ USC DRQS, United States
Dr Liberti has worked in pharmaceutical regulatory affairs, communications and clinical R&D for the past four decades. From 2009 to 2021 he served as the Executive Director of CIRS. He is the Director of the DK Kim International (USC DRQS) and has been actively involved in promulgating... Read More →
MM

Mallika Mundkur

Deputy Chief Medical Officer, OC, FDA, United States
KT

Kellie Taylor

VP, CMC Regulatory Affairs, Regeneron Pharmaceuticals, United States
Wednesday June 17, 2026 10:15am - 11:30am EDT
204AB The Pennsylvania Convention Center 1101 Arch Street Philadelphia, PA 19107 USA
  08: RegPolicy-Strategy-GlobalCollaboration, Forum
  • Audience Basic
  • Level Basic
  • format csv
  • Credit Type ACPE, CME, RN
  • Interest Area Regulatory
  • Tags Forum

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share

Get help with the event

Contact event planner Event login
View support guides Find upcoming events
Create an event you'd love to attend!
Explore why organizers choose Sched • Success stories
Event App • Event scheduling • Event registration • Event ticketing • Sched forms • Call for papers • Badges • Conferences
© 2026. SCHED LLC - All rights reserved - Helping events since 2008
Meeting Planning Software • Privacy • Terms
Share Modal

Share this link via

Or copy link